GloboScience Revenue and Competitors
Estimated Revenue & Valuation
- GloboScience's estimated annual revenue is currently $2.6M per year.
- GloboScience's estimated revenue per employee is $155,000
Employee Data
- GloboScience has 17 Employees.
- GloboScience grew their employee count by 6% last year.
GloboScience's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. Director, Marketing & Client Relations | Reveal Email/Phone |
GloboScience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is GloboScience?
WHO WE ARE Rapidly evolving scientific advancements and increasing regulatory uncertainty represent a complex environment in which to develop and commercialize new therapeutics. To assist you in addressing these challenges, GloboScience has assembled an exceptional team of international experts in regulatory science, pharmacology, toxicology, clinical development, pharmacovigilance, medical affairs, manufacturing and biostatistics. WHAT WE DO Whether you have a product in nonclinical or clinical development, GloboScience implements an experience-based approach to provide strategic, scientific and regulatory services that results in first cycle approvals and regulatory successes for our clients globally. Our approach allows us to focus and streamline our clients’ development efforts, reducing developmental time and costs. WHAT WE’VE DONE GloboScience’s experience as Drug Regulatory Authorities (DRAs) supervisors, reviewers, and industry strategists has forged a unique comprehension of the product-specific complexities and benefit-risk methodologies applicable to pharmaceuticals, biologics, medical devices, consumer health and new product development. OUR EXPERTISE • Pharmaceutical Drugs • Biologics • Medical Devices • Bioimiliars + Generics • Foods OUR SERVICES • Regulatory • Clinical and Nonclinical Development • Chemistry Manufacturing & Controls • Biostatistics • Pharmacovigilance SPECIALTY • Rare Diseases (Pathway Creation) • Complete Response Letters, Rejections, Appeals (Regulatory Rescue) • Indication Consulting (Optimized Development + Accelerated Filing)
keywords:N/AN/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 17 | -53% | N/A |
#2 | $1.5M | 17 | -6% | N/A |
#3 | $1.5M | 17 | -11% | N/A |
#4 | $1.5M | 17 | N/A | N/A |
#5 | $1.5M | 17 | N/A | N/A |